MEAGHER, M. F. Et Al. 2022. Cytoreductive Nephrectomy In Patients Receiving Tki Therapy Versus Immune Checkpoint Inhibitor Therapy: Analysis Of The REMARCC Registry. European Association of Urology Congress - 2022 , (Amsterdam, Netherlands).

MEAGHER, M. F., MINERVINI, A., MIR, M. C., REBEZ, G., AUTORINO, R., CAMPI, R., ... KRIEGMAIR, M.(2022). Cytoreductive Nephrectomy In Patients Receiving Tki Therapy Versus Immune Checkpoint Inhibitor Therapy: Analysis Of The REMARCC Registry . European Association of Urology Congress - 2022, Amsterdam, Netherlands

MEAGHER, MARGARET Et Al. "Cytoreductive Nephrectomy In Patients Receiving Tki Therapy Versus Immune Checkpoint Inhibitor Therapy: Analysis Of The REMARCC Registry," European Association of Urology Congress - 2022, Amsterdam, Netherlands, 2022

MEAGHER, MARGARET F. Et Al. "Cytoreductive Nephrectomy In Patients Receiving Tki Therapy Versus Immune Checkpoint Inhibitor Therapy: Analysis Of The REMARCC Registry." European Association of Urology Congress - 2022 , Amsterdam, Netherlands, 2022

MEAGHER, M. F. Et Al. (2022) . "Cytoreductive Nephrectomy In Patients Receiving Tki Therapy Versus Immune Checkpoint Inhibitor Therapy: Analysis Of The REMARCC Registry." European Association of Urology Congress - 2022 , Amsterdam, Netherlands.

@conferencepaper{conferencepaper, author={MARGARET F MEAGHER Et Al. }, title={Cytoreductive Nephrectomy In Patients Receiving Tki Therapy Versus Immune Checkpoint Inhibitor Therapy: Analysis Of The REMARCC Registry}, congress name={European Association of Urology Congress - 2022}, city={Amsterdam}, country={Netherlands}, year={2022}}